- ►annals.org [PDF] F Kronenberg, A Fugh-Berman - Annals of internal medicine, 2002 - Am Coll Physicians Background: Women commonly use soy products, herbs, and other complementary and
alternative medicine (CAM) therapies for menopausal symptoms. Randomized,
controlled trials have evaluated the efficacy and short-term safety of ... Cited by 321 - Related articles - BL Direct - All 6 versions
CAM THERAPIES - Ann Intern Med, 2002 - dumenat.smbh.univ-paris13.fr Background: Women commonly use soy products, herbs, and other complementary and
alternative medicine (CAM) therapies for menopausal symptoms. Randomized,
controlled trials have evaluated the efficacy and short-term safety of ... Related articles - View as HTML - All 6 versions
JA Tice, B Ettinger, K Ensrud, R Wallace, T … - Jama, 2003 - Am Med Assoc Context Clinical trials demonstrating increased risk of cardiovascular disease
and breast cancer among women randomized to hormone replacement therapy have
increased interest in other therapies for menopausal symptoms. Dietary ... Cited by 190 - Related articles - BL Direct - All 9 versions
- ►ucalgary.ca [PDF] AL Huntley, E Ernst - Menopause, 2003 - journals.lww.com A systematic review of herbal medicinal products for the ... Alyson L. Huntley,
PhD, and Edzard Ernst, MD ... ABSTRACT Objective: Many women have turned to
complementary and alternative medicines for relief from their menopausal ... Cited by 90 - Related articles - BL Direct - All 6 versions
- ►ascopubs.org JS Jacobson, AB Troxel, J Evans, L Klaus, L … - Journal of Clinical Oncology, 2001 - jco.ascopubs.org Add to CiteULike Add to Complore Add to Connotea Add to Del.icio.us Add to Digg
Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this? ...
From the Herbert Irving Comprehensive Cancer Center and Joseph L. Mailman ... Cited by 274 - Related articles - BL Direct - All 13 versions
W Wuttke, D Seidlova-Wuttke, C Gorkow - Maturitas, 2003 - Elsevier Objectives: In the present study, therapeutic effects of the Cimicifuga racemosa
preparation CR BNO 1055 (Klimadynon®/Menofem®) on climacteric complaints, bone
metabolism and endometrium will be compared with those of conjugated ... Cited by 161 - Related articles - All 5 versions
T Guttuso Jr, R Kurlan, MP McDermott, K … - Obstetrics & Gynecology, 2003 - journals.lww.com RESULTS: After 12 weeks of double-blind treatment, inten- tion-to-treat analysis
showed that gabapentin 900 mg per day was associated with a 45% reduction in hot
flash frequency and a 54% reduction in hot flash composite score (frequency ... Cited by 190 - Related articles - All 7 versions
A St Germain, CT Peterson, JG Robinson, DL … - Menopause, 2001 - journals.lww.com Isoflavone-rich or isoflavone-poor soy protein does not reduce ... Alison St.
Germain, MS, RD,1 Charles T. Peterson, MS,2 Jennifer G. Robinson, MD, MPH,3 and
D. Lee Alekel, PhD, RD1 ... ABSTRACT Objective: We examined the change in ... Cited by 154 - Related articles - BL Direct - All 3 versions
RJ Baber, C Templeman, T Morton, GE Kelly, … - Climacteric, 1999 - informahealthcare.com Page 1. CLIMACTERIC 1999;2:85-92 Randomized placebo-controlled trial of
an isoflavone supplement and menopausal symptoms in women ... Cited by 187 - Related articles - BL Direct - All 5 versions
- ►topalbertadoctors.org [PDF] HD Nelson, KK Vesco, E Haney, R Fu, A Nedrow … - Jama, 2006 - Am Med Assoc You are seeing this message because your Web browser does not support basic Web
standards. Find out more about why this message is appearing and what you can do
to make your experience on this site better. Cited by 211 - Related articles - BL Direct - All 8 versions
